Anti-Inflammatory Milk Matrix

Exclusion Criteria

• •Tobacco, nicotine (patch/gum) use (previous 6 mo)
• •Alcohol consumption \>10 drinks per week
• •Metabolic disorders (e.g., Metabolic Syndrome, Diabetes, thyroid diseases)
• •Cardiovascular disease, arrhythmias
• •Hypogonadism
• •Asthma
• •History of uncontrolled hypertension
• •Orthopedic injury/surgery (within 1 yr)
• •Hepatorenal, musculoskeletal, autoimmune, or neurological disease
• •History of neuromuscular problems
• •Previous participation in amino acid tracer studies
• •Predisposition to hypertrophic scarring or keloid formation
• •Consumption of ergogenic-levels of dietary supplements that may affect muscle mass (e.g., creatine, HMB), insulin-like substances, or anabolic/catabolic pro-hormones (e.g., DHEA) within 6 weeks prior to participation
• •Consumption of thyroid, androgenic, or other medications known to affect endocrine function
• •Consumption of medications known to affect protein metabolism (e.g., prescription-strength corticosteroids, non-steroidal anti-inflammatories, or acne medication)
• •Pregnancy
• •Allergy to dairy product or lactose intolerance
• •Fasting plasma glucose (FPG) ≥ 126 mg/dL
• •Oral glucose tolerance test (OGTT) ≥ 200 mg/dL